Presentation TCT 2015 Stroke and Bleeding Risk Scores: How to Use These in Practice Presenter: Brian K. Whisenant October 11, 2015 REGISTER for free or LOG IN to view this content Presentation TCT 2015 Up Next Presentation TCT 2015 Should FFR Be Used Routinely in STEMI Patients With Multivessel Disease, and Is It Reliable During the Index and/or Staged Procedures? Presenter: Colin Berry October 11, 2015 More slides + Presentation TCT 2015 Debate 2: Should Long-term (2 Years to Life) Dual Antiplatelet Therapy Be Used in Most Patients After MI? Yes, and the Data Are Strong for Ticagrelor (PEGASUS Trial)! Presenter: Neal S. Kleiman October 11, 2015 Presentation TCT 2015 How to Handle Outliers in the Lab Presenter: Michael A. Kutcher October 11, 2015 We Recommend
Presentation TCT 2015 Should FFR Be Used Routinely in STEMI Patients With Multivessel Disease, and Is It Reliable During the Index and/or Staged Procedures? Presenter: Colin Berry October 11, 2015
Presentation TCT 2015 Debate 2: Should Long-term (2 Years to Life) Dual Antiplatelet Therapy Be Used in Most Patients After MI? Yes, and the Data Are Strong for Ticagrelor (PEGASUS Trial)! Presenter: Neal S. Kleiman October 11, 2015
Presentation TCT 2015 How to Handle Outliers in the Lab Presenter: Michael A. Kutcher October 11, 2015